<DOC>
	<DOCNO>NCT00453336</DOCNO>
	<brief_summary>RATIONALE : Photodynamic therapy use drug becomes active expose certain kind light . When drug active , precancerous cell cancer cell kill . PURPOSE : This phase II trial study side effect well photodynamic therapy porfimer sodium work treat patient precancerous lesion , cancer , disease aerodigestive tract .</brief_summary>
	<brief_title>Photodynamic Therapy With Porfimer Sodium Treating Patients With Precancerous Lesions , Cancer , Other Disease Aerodigestive Tract</brief_title>
	<detailed_description>OBJECTIVES : - Determine efficacy photodynamic therapy porfimer sodium patient pre-malignant lesion , carcinoma situ , select superficial squamous cell carcinoma oral cavity , oropharynx , larynx , condemn mucosa syndrome upper aerodigestive tract . - Determine safety regimen patient . OUTLINE : Patients stratify accord disease condition ( benign v malignant ) . Patients receive porfimer sodium IV 3-5 minute day 1 laser light activation day 3 4 . After completion study treatment , patient follow 3 4 month periodically 2 year . PROJECTED ACCRUAL : A total 47 patient accrue study .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Dihematoporphyrin Ether</mesh_term>
	<mesh_term>Hematoporphyrin Derivative</mesh_term>
	<mesh_term>Trioxsalen</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis 1 following : Any following benign lesion : Localized severe dysplasia , leukoplakia , erythroplakia , superficial lesion consider premalignant Carcinoma situ Superficial ( &lt; 1 cm depth invasion ) squamous cell carcinoma ( SCC ) oral cavity , oropharynx , larynx T1T3 disease Meets one follow criterion : Failed radiation therapy refuse standard salvage surgery Refused radiation therapy and/or surgery primary therapy No good surgical alternative acceptable morbidity Condemned mucosa syndrome At least one upper aerodigestive tract premalignant lesion , carcinoma situ , squamous cell carcinoma previously treat surgery and/or radiation therapy development another lesion site previously treat area PATIENT CHARACTERISTICS : Creatinine ≤ 2 mg/dL AST ALT ≤ 30 % elevated Alkaline phosphatase ≤ 30 % elevated Bilirubin ≤ 1.0 mg/dL No contraindication anesthesia analgesia No porphyria No hypersensitivity porphyrins Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage II squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage I squamous cell carcinoma larynx</keyword>
	<keyword>stage I squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage I squamous cell carcinoma oropharynx</keyword>
	<keyword>oral leukoplakia</keyword>
</DOC>